Eli Lilly (LLY) Cash & Equivalents (2009 - 2026)
Eli Lilly's Cash & Equivalents was $4.89 billion in Q3 2026, down 50.1% from $9.79 billion a year earlier and down 45.4% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Eli Lilly came in at $7.27 billion, up 122.4% from FY2024.
- Cash & Equivalents has now increased for three consecutive years, with a five-year compound annual growth rate of 14.7% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $3.27 billion in FY2024 (+15.9%), $2.82 billion in FY2023 (+36.4%), $2.07 billion in FY2022 (-45.9%) and $3.82 billion in FY2021 (+4.4%).
- The Q3 2026 figure marks the lowest quarterly Cash & Equivalents since Q2 2025.
- Compared with a year earlier, Cash & Equivalents was higher in seven of the last eight quarters, with growth averaging 68.2%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q3 2025 (growth of 190.6%); the worst was Q3 2026 (a decline of 50.1%).
- Per Business Quant data, LLY's Cash & Equivalents in the three quarters before Q3 2026 was $8.95 billion (Q2 2026), $5.28 billion (Q1 2026) and $7.27 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 4.98 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.89 Bn |
| Jun 30, 2026 | 8.95 Bn |
| Mar 31, 2026 | 5.28 Bn |
| Dec 31, 2025 | 7.27 Bn |
| Sep 30, 2025 | 9.79 Bn |
| Jun 30, 2025 | 3.38 Bn |
| Mar 31, 2025 | 3.09 Bn |
| Dec 31, 2024 | 3.27 Bn |
| Sep 30, 2024 | 3.37 Bn |
| Jun 30, 2024 | 3.22 Bn |
| Mar 31, 2024 | 2.46 Bn |
| Dec 31, 2023 | 2.82 Bn |
| Sep 30, 2023 | 2.38 Bn |
| Jun 30, 2023 | 2.69 Bn |
| Mar 31, 2023 | 3.55 Bn |
| Dec 31, 2022 | 2.07 Bn |
| Sep 30, 2022 | 2.62 Bn |
| Jun 30, 2022 | 2.62 Bn |
| Mar 31, 2022 | 2.46 Bn |
| Dec 31, 2021 | 3.82 Bn |
API Access
Eli Lilly Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();